LULICONAZOLE

LULICONAZOLE was reported 176 times

LULICONAZOLE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 OESOPHAGEAL ATONY 2 0.2500
1 MYCOBACTERIUM AVIUM COMPLEX IMMUNE RESTORATION DISEASE 2 0.0690
2 APPLICATION SITE PURPURA 1 0.0625
3 MEDICAL DEVICE SITE BURN 1 0.0455
4 TRICHOPHYTIC GRANULOMA 1 0.0213
5 APPLICATION SITE CELLULITIS 1 0.0149
6 AMOEBIC COLITIS 1 0.0110
7 MUCOCUTANEOUS CANDIDIASIS 1 0.0108
8 SEGMENTED HYALINISING VASCULITIS 1 0.0098
9 TRICHOMONIASIS 1 0.0069
10 BASOSQUAMOUS CARCINOMA 1 0.0067
11 INTERLEUKIN-2 RECEPTOR INCREASED 1 0.0058
12 SCABIES 1 0.0058
13 ANTI-INSULIN ANTIBODY POSITIVE 1 0.0048
14 KL-6 INCREASED 1 0.0044
15 HAEMOPHILIC ARTHROPATHY 1 0.0042
16 METASTASES TO THORAX 1 0.0040
17 OVERGROWTH BACTERIAL 1 0.0037
18 PENILE BURNING SENSATION 1 0.0035
19 RENAL HYPERTENSION 1 0.0032
20 NECROTISING RETINITIS 2 0.0031
21 RECTAL STENOSIS 1 0.0030
22 INFECTED DERMAL CYST 1 0.0028
23 OCULOMUCOCUTANEOUS SYNDROME 1 0.0024
24 EYELID INFECTION 1 0.0023
25 ROOT CANAL INFECTION 1 0.0020
26 CORONAVIRUS TEST POSITIVE 2 0.0019
27 FULMINANT TYPE 1 DIABETES MELLITUS 2 0.0019
28 MYELODYSPLASTIC SYNDROME TRANSFORMATION 1 0.0019
29 SKIN CANDIDA 1 0.0019
30 TINEA PEDIS 3 0.0019
31 EOSINOPHIL PERCENTAGE INCREASED 1 0.0018
32 BURSITIS INFECTIVE 1 0.0018
33 EPIGLOTTITIS 1 0.0018
34 TINEA INFECTION 2 0.0018
35 SEROSITIS 1 0.0018
36 BODY TINEA 1 0.0018
37 ENANTHEMA 1 0.0017
38 LYMPHOCYTE MORPHOLOGY ABNORMAL 1 0.0017
39 ORAL MUCOSAL DISCOLOURATION 1 0.0015
40 CUTANEOUS SYMPTOM 1 0.0015
41 HAEMORRHAGIC CEREBRAL INFARCTION 1 0.0014
42 DYSLALIA 1 0.0014
43 LIP EROSION 1 0.0014
44 CREATINE KINASE INCREASED 1 0.0013
45 SEROUS RETINAL DETACHMENT 1 0.0012
46 PSEUDOMONAL BACTERAEMIA 1 0.0012
47 EOSINOPHILIC PNEUMONIA ACUTE 1 0.0012
48 PROTEIN URINE 1 0.0011
49 HEPATIC CONGESTION 1 0.0011
50 PENILE SIZE REDUCED 1 0.0011
51 PATIENT DISSATISFACTION WITH TREATMENT 2 0.0010
52 PRODUCT CLOSURE REMOVAL DIFFICULT 1 0.0010
53 TRAUMATIC HAEMATOMA 1 0.0009
54 NAIL GROWTH ABNORMAL 1 0.0009
55 DIABETIC NEPHROPATHY 2 0.0009
56 IMMUNE-MEDIATED HYPOTHYROIDISM 1 0.0009
57 MALIGNANT MELANOMA IN SITU 1 0.0008
58 APPLICATION SITE EROSION 1 0.0008
59 PERIODONTAL DISEASE 1 0.0007
60 CEREBELLAR HAEMORRHAGE 1 0.0007
61 NAIL INFECTION 1 0.0007
62 ORAL MUCOSAL ERUPTION 1 0.0007
63 COLONIC POLYP 1 0.0006
64 PLANTAR FASCIITIS 2 0.0006
65 KIDNEY FIBROSIS 1 0.0006
66 DEPRESSIVE SYMPTOM 2 0.0006
67 EPSTEIN-BARR VIRUS ASSOCIATED LYMPHOPROLIFERATIVE DISORDER 1 0.0006
68 CYTOMEGALOVIRUS TEST POSITIVE 1 0.0006
69 TRAUMATIC HAEMORRHAGE 1 0.0005
70 NARCOLEPSY 1 0.0005
71 HYPOPROTEINAEMIA 1 0.0005
72 CARCINOEMBRYONIC ANTIGEN INCREASED 1 0.0005
73 OCCULT BLOOD POSITIVE 1 0.0005
74 NAIL DISCOLOURATION 2 0.0005
75 LARGE INTESTINAL STENOSIS 1 0.0005
76 HYPERURICAEMIA 2 0.0005
77 RENAL NEOPLASM 1 0.0005
78 GASTRIC POLYPS 1 0.0004
79 VOLVULUS 1 0.0004
80 LACUNAR INFARCTION 1 0.0004
81 PANNICULITIS 1 0.0004
82 APPLICATION SITE BURN 2 0.0004
83 LUNG OPACITY 1 0.0004
84 ANIMAL BITE 1 0.0004
85 ULCERATIVE KERATITIS 1 0.0004
86 SPINAL COMPRESSION FRACTURE 3 0.0004
87 TUMOUR HAEMORRHAGE 1 0.0004
88 LUNG ADENOCARCINOMA 1 0.0003
89 CHOLANGITIS 2 0.0003
90 MULTIPLE-DRUG RESISTANCE 1 0.0003
91 SKIN EROSION 1 0.0003
92 HYPOGAMMAGLOBULINAEMIA 2 0.0003
93 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
94 INTERNATIONAL NORMALISED RATIO ABNORMAL 1 0.0003
95 TACHYPHRENIA 1 0.0003
96 PULMONARY TOXICITY 2 0.0003
97 DRUG ADMINISTERED TO PATIENT OF INAPPROPRIATE AGE 2 0.0003
98 MONOCYTE COUNT INCREASED 1 0.0003
99 SPONDYLITIS 1 0.0003
100 IMMUNE-MEDIATED ENTEROCOLITIS 1 0.0003
101 OESOPHAGEAL CANDIDIASIS 1 0.0003
102 ABNORMAL FAECES 2 0.0002
103 AORTIC DISSECTION 1 0.0002
104 HEPATIC FUNCTION ABNORMAL 9 0.0002
105 ONYCHOMADESIS 1 0.0002
106 VASCULAR DEVICE INFECTION 1 0.0002
107 URINE ABNORMALITY 1 0.0002
108 PANCREATIC DISORDER 1 0.0002
109 DIABETIC NEUROPATHY 1 0.0002
110 APPLICATION SITE SWELLING 1 0.0002
111 INCREASED UPPER AIRWAY SECRETION 1 0.0002
112 TONSILLITIS 1 0.0002
113 APLASTIC ANAEMIA 1 0.0002
114 ANAL FISTULA 1 0.0002
115 HYDROCEPHALUS 1 0.0002
116 INTERMENSTRUAL BLEEDING 1 0.0002
117 SKIN ATROPHY 1 0.0002
118 HYPERTRIGLYCERIDAEMIA 1 0.0002
119 COVID-19 PNEUMONIA 2 0.0002
120 BACTERAEMIA 2 0.0002
121 HEPATITIS C 2 0.0002
122 MENISCUS INJURY 1 0.0002
123 INCOHERENT 1 0.0002
124 ARTERIOSCLEROSIS CORONARY ARTERY 1 0.0002
125 MALIGNANT MELANOMA 2 0.0001
126 BRONCHIECTASIS 1 0.0001
127 APPLICATION SITE RASH 2 0.0001
128 AUTOIMMUNE HEPATITIS 1 0.0001
129 THERMAL BURN 1 0.0001
130 COLON CANCER 2 0.0001
131 PEMPHIGOID 1 0.0001
132 HYPOALBUMINAEMIA 1 0.0001
133 PRODUCT ADMINISTRATION INTERRUPTED 1 0.0001
134 BLOOD ALBUMIN DECREASED 1 0.0001
135 MYASTHENIA GRAVIS 1 0.0001
136 EOSINOPHIL COUNT INCREASED 1 0.0001
137 PYELONEPHRITIS 1 0.0001
138 NAIL DISORDER 1 0.0001
139 DRUG ERUPTION 2 0.0001
140 CEREBRAL HAEMORRHAGE 4 0.0001
141 HAEMARTHROSIS 1 0.0001
142 LUPUS-LIKE SYNDROME 1 0.0001
143 END STAGE RENAL DISEASE 2 0.0001
144 ERYTHEMA MULTIFORME 1 0.0001
145 TUBULOINTERSTITIAL NEPHRITIS 2 0.0001
146 LEUKAEMIA 1 0.0001
147 BLOOD URINE PRESENT 2 0.0001
148 CHOKING 2 0.0001
149 BLADDER DISORDER 1 0.0001
150 SUBARACHNOID HAEMORRHAGE 1 0.0001
151 HYPERBILIRUBINAEMIA 1 0.0001
152 TENDERNESS 1 0.0001
153 WEIGHT FLUCTUATION 1 0.0001
154 FOLLICULITIS 1 0.0001
155 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
156 EYE DISORDER 3 0.0001
157 APPLICATION SITE PAIN 2 0.0001
158 GAMMA-GLUTAMYLTRANSFERASE INCREASED 2 0.0001
159 SKIN DISORDER 3 0.0001
160 DERMATITIS CONTACT 1 0.0001
161 INTERSTITIAL LUNG DISEASE 4 0.0001
162 HYPERGLYCAEMIA 3 0.0001
163 CEREBRAL INFARCTION 2 0.0001
164 ILEUS 1 0.0001
165 CELLULITIS 4 0.0001
166 BRAIN OEDEMA 1 0.0001
167 METASTASES TO CENTRAL NERVOUS SYSTEM 1 0.0001
168 HIATUS HERNIA 1 0.0001
169 ADVERSE REACTION 1 0.0001
170 PNEUMONITIS 2 0.0001
171 OSTEOPOROSIS 3 0.0001
172 CARPAL TUNNEL SYNDROME 1 0.0001
173 BLISTER 4 0.0001
174 SLEEP DISORDER 5 0.0001
175 BRONCHOSPASM 1 0.0001
176 IMMUNODEFICIENCY 1 0.0001
177 HAEMORRHAGE INTRACRANIAL 1 0.0001
178 OSTEOPENIA 1 0.0001
179 TOXIC EPIDERMAL NECROLYSIS 1 0.0001
180 SKIN IRRITATION 3 0.0001
181 INSURANCE ISSUE 1 0.0001
182 ALANINE AMINOTRANSFERASE INCREASED 4 0.0001
183 PHARYNGEAL OEDEMA 1 0.0001
184 BLOOD LACTATE DEHYDROGENASE INCREASED 1 0.0001
185 PNEUMOTHORAX 1 0.0001
186 ABSCESS 1 0.0001
187 BLOOD POTASSIUM INCREASED 1 0.0001
188 MULTIPLE FRACTURES 1 0.0001
189 MANIA 1 0.0001
190 VENTRICULAR TACHYCARDIA 1 0.0001
191 EXPIRED PRODUCT ADMINISTERED 2 0.0001
192 LEUKOPENIA 3 0.0001
193 BLOOD UREA INCREASED 1 0.0001
194 EOSINOPHILIA 1 0.0001
195 LYMPHOCYTE COUNT DECREASED 1 0.0001
196 GOUT 1 0.0001
197 C-REACTIVE PROTEIN INCREASED 2 0.0001
198 CONJUNCTIVITIS 1 0.0001
199 DYSARTHRIA 2 0.0001
200 GASTRIC ULCER 1 0.0001
201 DRUG PRESCRIBING ERROR 1 0.0001
202 ACUTE RESPIRATORY FAILURE 1 0.0001
203 PRESCRIBED UNDERDOSE 1 0.0001
204 SPINAL FRACTURE 1 0.0000
205 TASTE DISORDER 1 0.0000
206 BONE MARROW FAILURE 1 0.0000
207 NEUTROPHIL COUNT DECREASED 2 0.0000
208 DERMATITIS 1 0.0000
209 HALLUCINATION, VISUAL 1 0.0000
210 JOINT INJURY 1 0.0000
211 FEBRILE NEUTROPENIA 3 0.0000
212 STEVENS-JOHNSON SYNDROME 1 0.0000
213 RASH MACULO-PAPULAR 1 0.0000
214 NEUROPATHY PERIPHERAL 4 0.0000
215 PRODUCT PRESCRIBING ERROR 1 0.0000
216 ENCEPHALOPATHY 1 0.0000
217 BLOOD ALKALINE PHOSPHATASE INCREASED 1 0.0000
218 GASTRIC CANCER 1 0.0000
219 HYPOPHAGIA 1 0.0000
220 ERECTILE DYSFUNCTION 1 0.0000
221 DRUG RESISTANCE 1 0.0000
222 SKIN ULCER 1 0.0000
223 HAEMATOMA 1 0.0000
224 ANHEDONIA 1 0.0000
225 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
226 CARDIAC FAILURE 3 0.0000
227 GASTROOESOPHAGEAL REFLUX DISEASE 3 0.0000
228 PAIN OF SKIN 1 0.0000
229 CONSTIPATION 8 0.0000
230 DIVERTICULITIS 1 0.0000
231 WOUND 1 0.0000
232 HYPONATRAEMIA 2 0.0000
233 MULTIPLE ORGAN DYSFUNCTION SYNDROME 1 0.0000
234 HERPES ZOSTER 2 0.0000
235 BLOOD CREATINE PHOSPHOKINASE INCREASED 1 0.0000
236 LIVER FUNCTION TEST ABNORMAL 1 0.0000
237 NEEDLE ISSUE 1 0.0000
238 MUSCULOSKELETAL STIFFNESS 3 0.0000
239 ASCITES 1 0.0000
240 ACUTE MYOCARDIAL INFARCTION 1 0.0000
241 CATARACT 2 0.0000
242 STOMATITIS 2 0.0000
243 PLEURAL EFFUSION 2 0.0000
244 DISCOMFORT 2 0.0000
245 EMOTIONAL DISORDER 1 0.0000
246 SWOLLEN TONGUE 1 0.0000
247 BONE DENSITY DECREASED 1 0.0000
248 DRUG-INDUCED LIVER INJURY 1 0.0000
249 METABOLIC ACIDOSIS 1 0.0000
250 DRUG INTOLERANCE 3 0.0000
251 BLOOD CREATININE INCREASED 2 0.0000
252 CHOLELITHIASIS 1 0.0000
253 INFUSION RELATED REACTION 2 0.0000
254 DECREASED APPETITE 7 0.0000
255 VIRAL INFECTION 1 0.0000
256 LIP SWELLING 1 0.0000
257 DEHYDRATION 4 0.0000
258 TRANSIENT ISCHAEMIC ATTACK 1 0.0000
259 HAEMATURIA 1 0.0000
260 HYPERKALAEMIA 1 0.0000
261 THERAPY INTERRUPTED 2 0.0000
262 INFECTION 4 0.0000
263 RESTLESSNESS 1 0.0000
264 BRONCHITIS 2 0.0000
265 SEPSIS 3 0.0000
266 THROMBOCYTOPENIA 3 0.0000
267 COLITIS 1 0.0000
268 CHRONIC KIDNEY DISEASE 2 0.0000
269 ANAEMIA 5 0.0000
270 BLOOD PRESSURE INCREASED 4 0.0000
271 ACUTE KIDNEY INJURY 4 0.0000
272 PERIPHERAL SWELLING 4 0.0000
273 PSORIATIC ARTHROPATHY 1 0.0000
274 ERYTHEMA 5 0.0000
275 RENAL IMPAIRMENT 2 0.0000
276 URINARY TRACT INFECTION 4 0.0000
277 PYREXIA 8 0.0000
278 VAGINAL HAEMORRHAGE 1 0.0000
279 SEPTIC SHOCK 1 0.0000
280 RENAL FAILURE 3 0.0000
281 DRY SKIN 3 0.0000
282 COLITIS ULCERATIVE 1 0.0000
283 GASTROINTESTINAL DISORDER 2 0.0000
284 THROAT IRRITATION 1 0.0000
285 THERAPY NON-RESPONDER 1 0.0000
286 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 4 0.0000
287 NO ADVERSE EVENT 4 0.0000
288 NEUTROPENIA 3 0.0000
289 SKIN DISCOLOURATION 1 0.0000
290 DYSPHAGIA 2 0.0000
291 DISEASE RECURRENCE 1 0.0000
292 MIGRAINE 2 0.0000
293 PRODUCTIVE COUGH 1 0.0000
294 CONTUSION 2 0.0000
295 HYPOGLYCAEMIA 1 0.0000
296 DYSPEPSIA 2 0.0000
297 DRY EYE 1 0.0000
298 DEPRESSED MOOD 1 0.0000
299 PLATELET COUNT DECREASED 2 0.0000
300 PNEUMONIA 6 0.0000
301 RASH PRURITIC 1 0.0000
302 OEDEMA 1 0.0000
303 TREATMENT NONCOMPLIANCE 1 0.0000
304 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
305 ANAPHYLACTIC REACTION 1 0.0000
306 ANXIETY 5 0.0000
307 DYSPHONIA 1 0.0000
308 SURGERY 1 0.0000
309 BLADDER CANCER 1 0.0000
310 OEDEMA PERIPHERAL 2 0.0000
311 VISUAL IMPAIRMENT 2 0.0000
312 EXPOSURE DURING PREGNANCY 1 0.0000
313 PRODUCT USE ISSUE 3 0.0000
314 LOSS OF CONSCIOUSNESS 2 0.0000
315 BLOOD PRESSURE DECREASED 1 0.0000
316 INSOMNIA 4 0.0000
317 NEOPLASM MALIGNANT 1 0.0000
318 HEPATIC ENZYME INCREASED 1 0.0000
319 MULTIPLE SCLEROSIS RELAPSE 1 0.0000
320 ABDOMINAL PAIN UPPER 3 0.0000
321 BURNING SENSATION 1 0.0000
322 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 1 0.0000
323 MOBILITY DECREASED 1 0.0000
324 RESPIRATORY FAILURE 1 0.0000
325 WEIGHT INCREASED 3 0.0000
326 EPISTAXIS 1 0.0000
327 HYPOAESTHESIA 2 0.0000
328 ACNE 1 0.0000
329 CONDITION AGGRAVATED 4 0.0000
330 ABDOMINAL PAIN 3 0.0000
331 DRUG INTERACTION 2 0.0000
332 PROSTATE CANCER 1 0.0000
333 INFLUENZA LIKE ILLNESS 1 0.0000
334 TREATMENT FAILURE 1 0.0000
335 FALL 4 0.0000
336 ABDOMINAL DISCOMFORT 2 0.0000
337 SKIN EXFOLIATION 1 0.0000
338 BALANCE DISORDER 1 0.0000
339 INTENTIONAL PRODUCT USE ISSUE 1 0.0000
340 COVID-19 2 0.0000
341 NAUSEA 9 0.0000
342 MUSCLE SPASMS 2 0.0000
343 PULMONARY EMBOLISM 1 0.0000
344 PRURITUS 4 0.0000
345 ATRIAL FIBRILLATION 1 0.0000
346 SYNCOPE 1 0.0000
347 CHEST DISCOMFORT 1 0.0000
348 HAEMOGLOBIN DECREASED 1 0.0000
349 ACCIDENTAL EXPOSURE TO PRODUCT 1 0.0000
350 ABDOMINAL DISTENSION 1 0.0000
351 HAEMORRHAGE 1 0.0000
352 DIARRHOEA 6 0.0000
353 WHITE BLOOD CELL COUNT DECREASED 1 0.0000
354 MALAISE 4 0.0000
355 DRUG INEFFECTIVE 12 0.0000
356 INFLUENZA 1 0.0000
357 GENERAL PHYSICAL HEALTH DETERIORATION 1 0.0000
358 BACK PAIN 2 0.0000
359 CHILLS 1 0.0000
360 EMOTIONAL DISTRESS 1 0.0000
361 PRODUCT USE IN UNAPPROVED INDICATION 2 0.0000
362 OFF LABEL USE 7 0.0000
363 PSORIASIS 1 0.0000
364 PRODUCT QUALITY ISSUE 1 0.0000
365 WEIGHT DECREASED 2 0.0000
366 RASH 3 0.0000
367 PARAESTHESIA 1 0.0000
368 DRUG DOSE OMISSION 1 0.0000
369 TREMOR 1 0.0000
370 DIZZINESS 3 0.0000
371 URTICARIA 1 0.0000
372 NASOPHARYNGITIS 1 0.0000
373 HYPERSENSITIVITY 1 0.0000
374 GAIT DISTURBANCE 1 0.0000
375 HYPOTENSION 1 0.0000
376 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 1 0.0000
377 HYPERTENSION 1 0.0000
378 VOMITING 2 0.0000
379 COUGH 1 0.0000
380 DYSPNOEA 2 0.0000
381 PRODUCT DOSE OMISSION ISSUE 1 0.0000
382 INJECTION SITE PAIN 1 0.0000
383 PAIN 2 0.0000
384 HEADACHE 2 0.0000
385 FATIGUE 2 0.0000
386 DEATH 1 0.0000